| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/14/2002 | WO2001022982A3 Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract |
| 03/14/2002 | WO2001020031A3 Polymorphisms in a klotho gene |
| 03/14/2002 | US20020032332 Hypotensive agents, antiallergens, antiasthma, treating bronchospasm, dysmenorrhea, esophageal spasm, glaucoma, premature labor, urinary tract disorder, gastrointestinal motility or cardiovascular disorders |
| 03/14/2002 | US20020032224 Treatment of inflammatory diseases and other diseases involving elevated levels of cytokines, as well as central nervous system disorders |
| 03/14/2002 | US20020032213 Macrolides |
| 03/14/2002 | US20020032212 A tricyclic compound (with oxy and nitrogen atoms in the ring); perticularly useful for treating or preventing psoriasis and other skin diseases |
| 03/14/2002 | US20020032204 Reacting a substituted indol-2-one compound with an acyclic or cyclic amine free of piperidine-1-yl or morpholine-4-yl to form protein kinase inhibitor |
| 03/14/2002 | US20020032202 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 03/14/2002 | US20020032191 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors |
| 03/14/2002 | US20020032181 For therapy of conditions or diseases that are estrogen-dependent, i.e., are estrogen-induced or estrogen-stimulated |
| 03/14/2002 | US20020031531 Immunotherapy for lung or urogenital cancer |
| 03/14/2002 | US20020031479 Medicaments |
| 03/14/2002 | DE4319554C2 Verwendung von Menthol zur peroralen entzündungshemmenden Behandlung von Asthma bronchiale The use of menthol for oral anti-inflammatory treatment of bronchial asthma |
| 03/14/2002 | DE10042997A1 Thienopyrimidine Thienopyrimidines |
| 03/14/2002 | DE10041217A1 Verwendung von Dihydroboswelliasäuren oder hydrierten Extrakten aus Boswellia zur prophylaktischen und/oder therapeutischen Behandlung von unerwünschten körperlichen oder seelischen Zuständen Use of Dihydroboswelliasäuren or hydrogenated extracts of Boswellia for prophylactic and / or therapeutic treatment of unwanted physical or mental conditions |
| 03/14/2002 | CA2422204A1 Human antibodies against pseudomonas aeruginosa lps derived from transgenic mice |
| 03/14/2002 | CA2421922A1 Proteases |
| 03/14/2002 | CA2421502A1 A method for treating allergies |
| 03/14/2002 | CA2419653A1 Prevention of acute sinusitis and sinus attack |
| 03/14/2002 | CA2419601A1 The treatment of inflammatory disorders |
| 03/14/2002 | CA2417177A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/14/2002 | CA2412279A1 "pseudo"-native chemical ligation |
| 03/14/2002 | CA2412278A1 Polymer-modified synthetic proteins |
| 03/14/2002 | CA2412277A1 Synthetic erythropoiesis stimulating proteins |
| 03/13/2002 | EP1186594A1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 03/13/2002 | EP1185700A1 49 human secreted proteins |
| 03/13/2002 | EP1185549A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 03/13/2002 | EP1185543A1 50 human secreted proteins |
| 03/13/2002 | EP1185542A2 Purine derivatives |
| 03/13/2002 | EP1185540A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents |
| 03/13/2002 | EP1185529A1 Pyrazolobenzodiazepines as cdk2 inhibitors |
| 03/13/2002 | EP1185522A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions containing them |
| 03/13/2002 | EP1185516A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 03/13/2002 | EP1185316A1 Devices and compounds for treating arterial restenosis |
| 03/13/2002 | EP1185302A2 Specifically targeted catalytic antagonists and uses thereof |
| 03/13/2002 | EP1185285A1 49 human secreted proteins |
| 03/13/2002 | EP1185284A1 47 human secreted proteins |
| 03/13/2002 | EP1185271A1 Il-8 receptor antagonists |
| 03/13/2002 | EP1185263A2 Receptor agonists and antagonists |
| 03/13/2002 | EP1185247A1 Anti-inflammatory bioactive glass particulates |
| 03/13/2002 | EP0983249B1 Processes and intermediates for preparing substituted indazole derivatives |
| 03/13/2002 | EP0977749B1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 03/13/2002 | CN1340060A Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant |
| 03/13/2002 | CN1340058A Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 03/13/2002 | CN1340049A 4-heterocyclylsulfonamide)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl-or-pyridylpyrimidines as endothelin receptor antagonists |
| 03/13/2002 | CN1340044A Nervinolin derivatives |
| 03/13/2002 | CN1340043A Phenylalaninol derivatives |
| 03/13/2002 | CN1339965A Combinations of formoterol and fluticasone propionate for asthma |
| 03/13/2002 | CN1339311A Throat powder |
| 03/13/2002 | CN1339310A Shaddock-lozenge tablet and its producing method |
| 03/13/2002 | CN1339299A Method for preparing medicine for urogenital system |
| 03/13/2002 | CN1080718C Vitamin D amine and amine derivatives |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355695 Antihistamines; asthma therapy |
| 03/12/2002 | US6355689 Antiinflammatory agents |
| 03/12/2002 | US6355670 Skin disorders |
| 03/12/2002 | US6355666 Protected forms of pharmacologically active agents and uses therefor |
| 03/12/2002 | US6355662 Peptide and nonpeptides autoimmune diseases, antiinflammatory agents |
| 03/12/2002 | US6355658 Coumarin derivatives, methods of preparation and application as medicines |
| 03/12/2002 | US6355653 Amino-triazolopyridine derivatives |
| 03/12/2002 | US6355640 Pyrazolopyridine adenosine antagonists |
| 03/12/2002 | US6355258 Method for formulating spill resistant pharmaceutical compositions in semi-solid form |
| 03/07/2002 | WO2002018938A1 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 03/07/2002 | WO2002018623A2 Methods and reagents for protease inhibition |
| 03/07/2002 | WO2002018583A2 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 03/07/2002 | WO2002018575A2 Genes expressed in the cell cycle |
| 03/07/2002 | WO2002018553A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/07/2002 | WO2002018540A2 Pyridine derivatives useful as cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications |
| 03/07/2002 | WO2002018445A2 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 03/07/2002 | WO2002018422A1 Amino acid substitution mutants of interleukin 13 |
| 03/07/2002 | WO2002018395A1 Phosphate derivatives as immunoregulatory agents |
| 03/07/2002 | WO2002018389A2 Thienopyrimidine |
| 03/07/2002 | WO2002018382A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 03/07/2002 | WO2002018380A1 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation |
| 03/07/2002 | WO2002018379A2 7-oxo pyridopyrimidines |
| 03/07/2002 | WO2002018373A1 Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof |
| 03/07/2002 | WO2002018370A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 03/07/2002 | WO2002018350A1 Grk inhibitor |
| 03/07/2002 | WO2002018341A2 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 03/07/2002 | WO2002018335A1 Cyclic amine derivatives |
| 03/07/2002 | WO2002018320A2 INHIBITORS OF α4 MEDIATED CELL ADHESION |
| 03/07/2002 | WO2002017914A2 Fused pyrrolocarbazoles against inflammation |
| 03/07/2002 | WO2002017894A2 Pharmaceutical formulation of salmeterol and fluticasone propionate |
| 03/07/2002 | WO2002017880A2 Nitric oxide-producing hydrogel materials |
| 03/07/2002 | WO2002017878A1 Lung surfactant compositions with dynamic swelling behaviour |
| 03/07/2002 | WO2001090103A9 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 03/07/2002 | WO2001077100A3 Benzoamide piperidine compounds as substance p antagonists |
| 03/07/2002 | WO2001068033A3 Il-8 receptor antagonists |
| 03/07/2002 | WO2001060414A3 Genetic modification of the lung as a portal for gene delivery |
| 03/07/2002 | WO2001060407A3 Novel combination of non-sedative anti-histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjunctivitis |
| 03/07/2002 | WO2001058956A3 Antibodies that bind human interleukin-18 and methods of making and using |
| 03/07/2002 | WO2001058949A3 Heterologous polypeptide of the tnf family |
| 03/07/2002 | WO2001057022A3 Pyrazole compositions useful as inhibitors of erk |
| 03/07/2002 | WO2001055178A3 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 03/07/2002 | WO2001043761A3 Methods for treating and preventing damage to mucosal tissue |
| 03/07/2002 | WO2001043692A3 SALTS OF Cis-4-CYANO-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID |
| 03/07/2002 | WO2001032888A3 Human transferase molecules |
| 03/07/2002 | WO2001021163A3 Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
| 03/07/2002 | WO2001021162A3 Treating allergic and inflammatory conditions using desloratadine |
| 03/07/2002 | US20020028953 Process for preparing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-acetic acid |